About NX Prenatal
NX Prenatal is a company based in Louisville (United States) founded in 2010 by Brian Brohman. It operates as a HealthTech. NX Prenatal has raised $5.76 million across 5 funding rounds from investors including Johnson & Johnson Innovation. NX Prenatal offers products and services including Preterm Birth Testing, Preeclampsia Detection, and Placenta Accreta Detection. NX Prenatal operates in a competitive market with competitors including Sera Prognostics, Mirvie, Pregnolia, DotLab and Yourgene Health, among others.
- Headquarter Louisville, United States
- Founders Brian Brohman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nx Prenatal Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.76 M (USD)
in 5 rounds
-
Latest Funding Round
$3.13 M (USD), Series A
Aug 21, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NX Prenatal
NX Prenatal offers a comprehensive portfolio of products and services, including Preterm Birth Testing, Preeclampsia Detection, and Placenta Accreta Detection. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood tests for preterm birth risk are provided early.
Early detection of preeclampsia risk is enabled through testing.
Technology for detecting placenta accreta is offered accurately.
Unlock access to complete
Unlock access to complete
Funding Insights of NX Prenatal
NX Prenatal has successfully raised a total of $5.76M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $3.13 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $3.1M
-
First Round
First Round
(02 Nov 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2023 | Amount | Series A - NX Prenatal | Valuation |
investors |
|
| Oct, 2022 | Amount | Grant - NX Prenatal | Valuation |
investors |
|
| Nov, 2020 | Amount | Series A - NX Prenatal | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NX Prenatal
NX Prenatal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Johnson & Johnson Innovation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NX Prenatal
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NX Prenatal
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nx Prenatal Comparisons
Competitors of NX Prenatal
NX Prenatal operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sera Prognostics, Mirvie, Pregnolia, DotLab and Yourgene Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sera Prognostics is focused on women's health diagnostics.
|
|
| domain | founded_year | HQ Location |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
|
| domain | founded_year | HQ Location |
Preterm birth risks are predicted using cervical stiffness measurement devices.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic testing for endometriosis is provided via saliva-based biomarkers.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| domain | founded_year | HQ Location |
Digital women's health management software for employers and individuals
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nx Prenatal
Frequently Asked Questions about NX Prenatal
When was NX Prenatal founded?
NX Prenatal was founded in 2010 and raised its 1st funding round 7 years after it was founded.
Where is NX Prenatal located?
NX Prenatal is headquartered in Louisville, United States. It is registered at Louisville, Kentucky, United States.
Who is the current CEO of NX Prenatal?
Brian Brohman is the current CEO of NX Prenatal. They have also founded this company.
Is NX Prenatal a funded company?
NX Prenatal is a funded company, having raised a total of $5.76M across 5 funding rounds to date. The company's 1st funding round was a Series A of $72K, raised on Nov 02, 2017.
What does NX Prenatal do?
NX Prenatal is engaged in advancing maternal and fetal health by developing molecular blood tests. These tests are designed to provide early insights into conditions such as preterm birth, preeclampsia, and placenta accreta. The company collaborates with leading institutions to enable personalized healthcare delivery in the maternal-fetal medicine sector. Solutions are aimed at reducing complications and improving outcomes for mothers and babies through early detection and tailored health strategies.
Who are the top competitors of NX Prenatal?
NX Prenatal's top competitors include Mirvie, Syrona Health and DotLab.
What products or services does NX Prenatal offer?
NX Prenatal offers Preterm Birth Testing, Preeclampsia Detection, and Placenta Accreta Detection.
Who are NX Prenatal's investors?
NX Prenatal has 1 investor. Key investors include Johnson & Johnson Innovation.